Literature DB >> 33726015

Open and/or laparoscopic one-stage resections of primary colorectal cancer and synchronous liver metastases: An observational study.

Hiroaki Nozawa1, Takeaki Ishizawa2, Hideo Yasunaga3, Hiroaki Ishii1, Hirofumi Sonoda1, Shigenobu Emoto1, Koji Murono1, Kazuhito Sasaki1, Kazushige Kawai1, Nobuhisa Akamatsu2, Junichi Kaneko2, Junichi Arita2, Kiyoshi Hasegawa2, Soichiro Ishihara1.   

Abstract

ABSTRACT: One-stage resections of primary colorectal cancer and liver metastases have been reported to be feasible and safe. Minimally invasive approaches have become more common for both colorectal and hepatic surgeries. This study aimed to investigate outcomes of these combined surgical procedures among different approaches.We retrospectively analyzed patients diagnosed as having primary colorectal cancer with synchronous liver metastases and who underwent 1-stage primary resection and hepatectomy with curative intent in our hospital. According to the surgical approach for the primary tumor and hepatic lesions, namely open laparotomy (Op) or laparoscopic approach (Lap), patients were classified into Op-Op, Lap-Op (laparoscopic colorectal resection plus open hepatectomy), and Lap-Lap groups, respectively. Clinicopathological factors were reviewed, and short- and long-term outcomes were compared among the groups.The Op-Op, Lap-Op, and Lap-Lap groups comprised 36, 18, and 17 patients, respectively. The superior/posterior hepatic segments were more frequently resected via an open approach. There was no laparoscopic major hepatectomy. The median volume of intraoperative blood loss was smaller in the Lap-Lap and Lap-Op groups (290 and 270 mL) than in the Op-Op group (575 mL, P = .008). The hospital stay after surgery was shorter in the Lap-Lap and Lap-Op groups (median: 17 days and 15 days, vs 19 days for the Op-Op group, P = .033). The postoperative complication rates and survivals were similar among the groups.Application of laparoscopy to 1-stage resections of primary colorectal cancer and liver metastases may offer advantages of enhanced recovery from surgical treatment, given appropriate patient selection.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33726015      PMCID: PMC7982201          DOI: 10.1097/MD.0000000000025205

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  37 in total

1.  Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study.

Authors:  Stefano Ferretti; Hadrien Tranchart; Joseph F Buell; Constantino Eretta; Alberto Patriti; Marcello Giuseppe Spampinato; Jung Wook Huh; Luca Vigano; Ho Seong Han; Giuseppe Maria Ettorre; Elio Jovine; Thomas Clark Gamblin; Giulio Belli; Go Wakabayashi; Brice Gayet; Ibrahim Dagher
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 2.  Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases: a systematic review.

Authors:  R M Lupinacci; W Andraus; L B De Paiva Haddad; L A Carneiro D' Albuquerque; P Herman
Journal:  Tech Coloproctol       Date:  2013-09-21       Impact factor: 3.781

3.  Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Authors:  René Adam; Valérie Delvart; Gérard Pascal; Adrian Valeanu; Denis Castaing; Daniel Azoulay; Sylvie Giacchetti; Bernard Paule; Francis Kunstlinger; Odile Ghémard; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

4.  Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial.

Authors:  Antonio M Lacy; Juan C García-Valdecasas; Salvadora Delgado; Antoni Castells; Pilar Taurá; Josep M Piqué; Josep Visa
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

5.  Randomized clinical trial comparing two vessel-sealing devices with crush clamping during liver transection.

Authors:  A Ichida; K Hasegawa; T Takayama; H Kudo; Y Sakamoto; S Yamazaki; Y Midorikawa; T Higaki; Y Matsuyama; N Kokudo
Journal:  Br J Surg       Date:  2016-09-29       Impact factor: 6.939

6.  Impact of totally laparoscopic combined management of colorectal cancer with synchronous hepatic metastases on severity of complications: a propensity-score-based analysis.

Authors:  Francesca Ratti; Marco Catena; Saverio Di Palo; Carlo Staudacher; Luca Aldrighetti
Journal:  Surg Endosc       Date:  2016-03-04       Impact factor: 4.584

7.  Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.

Authors:  Martijn Hgm van der Pas; Eva Haglind; Miguel A Cuesta; Alois Fürst; Antonio M Lacy; Wim Cj Hop; Hendrik Jaap Bonjer
Journal:  Lancet Oncol       Date:  2013-02-06       Impact factor: 41.316

Review 8.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

9.  Simultaneous Pure Laparoscopic Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: A Single Institution Experience with Propensity Score Matching Analysis.

Authors:  Arpad Ivanecz; Bojan Krebs; Andraz Stozer; Tomaz Jagric; Irena Plahuta; Stojan Potrc
Journal:  Radiol Oncol       Date:  2017-11-01       Impact factor: 2.991

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  1 in total

1.  Outcomes of simultaneous laparoscopic, hybrid, and open resection in colorectal cancer with synchronous liver metastases: a propensity score-matched study.

Authors:  Han-Ki Lim; Minjung Kim; Ji Won Park; Seung-Bum Ryoo; Kyu Joo Park; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Heung-Kwon Oh; Duck-Woo Kim; Sung-Bum Kang; Jai Young Cho; Dong-Woon Lee; Sung Chan Park; Jae Hwan Oh; Aesun Shin; Seung-Yong Jeong
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.